Alpha Cognition (ACOG) Cash from Financing Activities (2023 - 2025)
Alpha Cognition (ACOG) posted quarterly Cash from Financing Activities of $37.7 million for Q4 2025, down 19.99% year-over-year from $47.1 million in Q4 2024, and up 2675.78% quarter-over-quarter from $1.4 million in Q3 2025.
Alpha Cognition (ACOG) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Alpha Cognition's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $37.7 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 19.99% year-over-year to $37.7 million; the TTM figure through Dec 2025 stood at $38.2 million (down 30.33% YoY), while the FY2025 annual figure was $38.2 million, down 30.33% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $37.7 million, up from $1.4 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $47.1 million in Q4 2024, with the low at -$834303.0 in Q1 2025.
- The 3-year median for Cash from Financing Activities is $2.0 million (2023), against an average of $9.7 million.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 1700.85% in 2024, then sank 124.54% in 2025.
- Alpha Cognition's Cash from Financing Activities stood at $2.6 million in 2023, then surged by 1700.85% to $47.1 million in 2024, then decreased by 19.99% to $37.7 million in 2025.
- Business Quant data shows ACOG's Cash from Financing Activities at $37.7 million in Q4 2025, $1.4 million in Q3 2025, and -$10808.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.70 Mn |
| Dec 31, 2025 | 37.70 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | -10,808.00 |
| Jun 30, 2025 | -10,808.00 |
| Mar 31, 2025 | -834,303.00 |
| Mar 31, 2025 | -834,303.00 |
| Dec 31, 2024 | 47.12 Mn |
| Dec 31, 2024 | 47.12 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 173,443.00 |
| Jun 30, 2024 | 173,443.00 |
| Mar 31, 2024 | 3.40 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |